VANATAB DX description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

VANATAB DX

GM Pharmaceuticals, Inc.

VANATAB DX


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active ingredients
Chlophedianol Hydrochoride 12.5 mg
Guaifenesin 200 mg
Pseudoephedrine Hydrochloride 30 mg

Purpose

Cough Suppressant
Expectorant
Nasal Decongestant

VANATAB DX Uses

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

  • cough due to minor throat and bronchial irritation
  • helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive
  • nasal congestion
  • reduces swelling of nasal passages

Warnings

Do not exceed recommended dosage.

Do not use this product

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

Ask a doctor before use if you have

  • a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • a cough that occurs with too much phlegm (mucus)
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • trouble urinating due to an enlarged prostate gland
  • a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • a cough that occurs with too much phlegm (mucus)

Stop use and ask a doctor if

  • nervousness, dizziness, or sleeplessness occur
  • cough or nasal congestion persists for more than1 week, tends to recur, or is accompanied by fever, rash or persistent headache.  A persistent cough may be a sign of a serious condition.
  • new symptoms occur

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Do not exceed recommended dosage.
Adults and children
12 years of age
and over:

2 tablets every
6 hours, not
to exceed 8 tablets in a
24 hour period
Children 6 to under
12 years of age:


1 tablet every
6 hours, not to
exceed 4 tablets in a
24 hour period
Children under
6 years of age:
Consult a physician


VANATAB DX Other information

Store at 59°- 86°F (15°- 30°C)

Inactive ingedients

Dicalcium Phosphate Dihydrate, Croscarmellose Sodium, Silicone Dioxide, Stearic Acid, and Microcrystalline Cellulose

Questions? Comments?

Serious side effects may be reported to this number, call 1-888-535-0305, 8:00 AM - 5:00 PM Monday - Friday, Central time.

Product Packaging

The packaging below represents the labeling currently used.

Principal display panel and side panel for 100 tablets label:

NDC 58809-407-01

VANATAB DX

EACH TABLET CONTAINS:
Chlophedianol Hydrochloride................12.5 mg
Guaifenesin.........................................200 mg
Pseudoephedrine Hydrochloride..............30 mg

Cough Suppressant
Expectorant
Nasal Decongestant

100 Tablets

GM Pharmaceuticals, Inc.

Tamper evident by foil seal under cap.
Do not use if safety band is broken or missing.

Supplied in a tight, light-resistant container with
a child-resistant cap.

Patent Pending

Distributed by:
GM Pharmaceuticals, Inc.
Arlington, TX  76012

Rev. 04/11

VANATAB DX


VANATAB DX


VANATAB DX



VANATAB DX

Chlophedianol Hydrochloride, Guaifenesin, Pseudoephedrine Hydrochloride TABLET

Product Information

Product Type Human otc drug label Item Code (Source) NDC:58809-407
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Chlophedianol Hydrochloride Chlophedianol 12.5 mg
Guaifenesin GUAIFENESIN 200 mg
Pseudoephedrine Hydrochloride Pseudoephedrine 30 mg

Inactive Ingredients

Ingredient Name Strength
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
CROSCARMELLOSE SODIUM
SILICON DIOXIDE
STEARIC ACID
cellulose, microcrystalline

Product Characteristics

Color Size Imprint Code Shape
white 17 mm VTDX OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:58809-407-01 100 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part341 2011-09-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.